Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria

by Konstantin Tachkov, Zornitsa Mitkova, Vladimira Boyadzieva, Guenka Petrova
Published 2021-01-01